Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 677

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 677
---
                     |
|                                 |     | Name:           |     | Kobi Maimon (Jacob) |
|                                 |     | Title:          |     | Director            |

| COMPANY         |     |                 |     |                         |
| Kadimastem Ltd. |     |                 |     |                         |
| By              |     | /s/ Ronen Twito |     |                         |
|                 |     | Name:           |     | Ronen Twito             |
|                 |     | Title:          |     | Executive Chairman      |
| By              |     | /s/ Uri Ben Or  |     |                         |
|                 |     | Name:           |     | Uri Ben Or              |
|                 |     | Title:          |     | Chief Financial Officer |

[Signature page to Agreement Of Merger And Plan Of Reorganization]

Annex A-63 AMENDMENT TO THE AGREEMENT OF MERGER AND PLAN OF REORGANIZATION This Amendment, dated January 30, 2025 (this “ Amendment ”) to the Agreement of Merger and Plan of Reorganization dated November 4, 2024 (the “ Agreement ”) between Kadimastem Ltd., an Israeli publicly traded company limited by shares (“ Kadimastem ”), NLS Pharmaceutics Ltd., a corporation incorporated under the laws of Switzerland and includes any successor company thereto (the “ NLS ”), and NLS Pharmaceuticals (Israel) Ltd., an Israeli company (and together with Kadimastem and NLS, the “ Parties ”). WHEREAS , the Parties are parties to the Agreement, and WHEREAS, the Parties desire to amend the Agreement to clarify their intentions with respect to the terms of the terms thereof. NOW, THEREFORE , for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: 1.Section 5 is amended to add the following subsection 5.19 immediately at the end of such Section: The Parties agree that if any holder of Shares as of immediately prior to the Effective Time is entitled to receive Merger Consideration that would result in such holder owning Parent Common Stock in excess of the Beneficial Ownership Limitation (such excess amount of shares, the “ Excess Beneficial Ownership Shares ”), the Merger Consideration received by such holder shall be as provided for in Article II hereof except that any Merger Consideration in excess of the Beneficial Ownership Limitation shall be issued by Parent as pre